Harvard Apparatus Regenerative Technology, Inc. (HRGN)
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Last price
- $1.91
- As of
Kresmion compiles this page from HRGN's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Harvard Apparatus Regenerative Technology, Inc. (HRGN): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-14.
See the full HRGN dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for HRGN on one page. Preview it with sample data, then open it live with a free account.
Preview the HRGN dossierActive events for HRGN
No recent events on HRGN in the last 180 days.
FREE, NO ACCOUNT
Every event on HRGN, as it fires
New filings, 13F moves and cross asset events on HRGN land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter.
Recent SEC filings, HRGN
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
Going concern statement
HRGN's 10-Q filed Aug 13, 2026 states:
Because these resources are not expected to fund the Company's operations for at least 12 months from the date the financial statements are issued, substantial doubt exists about the Company's ability to continue as a going concern.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on HRGN
HRGN against its peers
HRGN's operating margin of -982.2% ranks in the 21st percentile of 16 Packaged Foods sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-06-30.
| Metric | HRGN | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 704000 USD | 49.9M USD | 28 | 15 |
| Revenue YoY | n/a | 37.0% | n/a | 5 |
| Gross margin | 8.2% | 25.5% | 9 | 16 |
| Operating margin | -982.2% | -15.6% | 21 | 16 |
| Net margin | -975.7% | -22.5% | 19 | 17 |
| Return on equity | -649.9% | -42.8% | 4 | 13 |
Peers (19): BHST, BOF, BRID, HOST, JVA, CLNN, LSF, GWLL, CFOO, STCB, LFVN, FTLF, BRLS, UMEW, COOT, HAIN, ENHA, WYHG, DDC. Left out: FRFAF (no annual filing), NPRFF (no annual filing), SRXH (no annual filing), GBCMY (no annual filing), BRCNF (period gap), GLUC (period gap). Fiscal periods ending between 2025-06-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (HRGN: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in HRGN on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on HRGN in the last 180 days.
Upstream: SEC EDGAR filings for HRGN
Kresmion, "Harvard Apparatus Regenerative Technology, Inc. (HRGN) institutional holdings and SEC filings", data as of 2026-09-14, https://kresmion.com/research/HRGN. Upstream data: SEC EDGAR filings for HRGN.
Link to this data (HTML):
<a href="https://kresmion.com/research/HRGN">Harvard Apparatus Regenerative Technology, Inc. (HRGN) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow HRGN on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to HRGN for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.